Stay updated on Inotuzumab Ozogamicin in B-ALL Clinical Trial
Sign up to get notified when there's something new on the Inotuzumab Ozogamicin in B-ALL Clinical Trial page.

Latest updates to the Inotuzumab Ozogamicin in B-ALL Clinical Trial page
- Check2 days agoChange DetectedAdded revision v3.5.0 to the record history and removed revision v3.4.3.SummaryDifference0.1%

- Check9 days agoChange DetectedOn 2026-03-10, the record was updated to add core sections—Contacts/Locations, Study Description, Study Status, and Study Identification—and the page revision progressed to v3.4.3 (following the previous v3.4.2 deletion on 2026-02-23).SummaryDifference0.4%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedVersion 51 (2026-02-20) updates the study record with new Contacts/Locations and an updated Study Status.SummaryDifference0.3%

- Check31 days agoChange DetectedOn 2026-02-17, core study sections such as Contacts/Locations, Eligibility, Outcome Measures, Arms and Interventions, Study Design, Study Description, and Study Status were added. A separate entry labeled 50 appeared on 2026-02-12, and an older entry from 2025-12-22 was deleted.SummaryDifference0.5%

- Check38 days agoChange DetectedA new revision entry, Revision: v3.4.2, was added to the history, and the previous funding/operating-status notice was removed. These are maintenance updates and do not affect the study information.SummaryDifference0.4%

- Check45 days agoChange DetectedA site-wide funding notice was added and the page shows a new revision tag (v3.4.1); the previous revision tag (v3.4.0) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Inotuzumab Ozogamicin in B-ALL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inotuzumab Ozogamicin in B-ALL Clinical Trial page.